Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia will have access to mRNA vaccine technology. Is that enough?

The company is under scrutiny over vaccine equity. It received considerable U.S. government help in developing its vaccine.

Especially the elderly and marginalized communities.